Spinal Ependymoma in Children

Status: draft · Last updated 2026-11-16 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Get a molecular diagnosis on every spinal ependymoma. MYCN amplification marks a disseminating, early-relapsing tumor, often intradural extramedullary .
  • Pediatric myxopapillary ependymoma is grade 2 and seeds the neuraxis. Up to half are disseminated at diagnosis, so image the whole neuraxis .
  • Remove an MPE en bloc with the capsule intact: that gave no recurrences, against 15% after capsular violation .
  • Intramedullary SP-EPN: a central tumor with a cap sign or syrinx usually has a plane. Extent of resection drives PFS .
  • NF2: watch asymptomatic cervical ependymomas, and operate for symptoms .
  • Children nearly always survive. Measure success by function, continence and spinal alignment as well as by PFS .

Spinal ependymomas are uncommon before adolescence. In children they behave differently from adult spinal ependymomas .

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:spinal_ependymoma_types:3c239c8d4d32e601© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Sagittal views: SP-EPN, a central cervical intramedullary ependymoma with polar cysts and hemosiderin caps; SP-MPE, a sausage-shaped myxopapillary ependymoma on the filum terminale displacing the cauda equina, with a drop metastasis; and SP-EPN-MYCN, an intradural extramedullary thoracic mass with nodular leptomeningeal disseminationSP-EPNC2C3C4C5C6C7T1polar cysthemosiderincapsymmetricexpansionSP-MPET12L1L2L3L4L5conus (L1)encapsulatedmass on filumcauda equinadisplaceddropmetastasisSP-EPN-MYCNT4T5T6T7T8T9T10intraduralextramedullarymassnodularleptomeningealcoatingsagittal, anterior left; schematic, not to scale
Pediatric spinal ependymoma types, sagittal. SP-EPN: central intramedullary cervical tumor with polar cysts and a hemosiderin cap. SP-MPE: encapsulated, sausage-shaped tumor on the filum terminale displacing the cauda equina, with a drop metastasis in the distal sac. SP-EPN-MYCN: intradural extramedullary thoracic mass with nodular leptomeningeal spread. Original schematic, not to scale.

Classification (WHO 2021 and methylation)

The aggressive one: SP-EPN-MYCN

Myxopapillary ependymoma in children

Intramedullary spinal ependymoma (SP-EPN)

NF2-related schwannomatosis

Follow-up and late effects

Related topics

References

  1. Pajtler KW, Witt H, Sill M, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27(5):728–743. doi:10.1016/j.ccell.2015.04.002. PMID 25965575. verified
  2. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106. PMID 34185076. verified
  3. Engertsberger L, Benesch M, Mynarek M, et al. Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: results from the HIT-MED database. Neurooncol Adv 2024;6(1):vdae179. doi:10.1093/noajnl/vdae179. PMID 39713042. verified
  4. Ghasemi DR, Sill M, Okonechnikov K, et al. MYCN amplification drives an aggressive form of spinal ependymoma. Acta Neuropathol 2019;138(6):1075–1089. doi:10.1007/s00401-019-02056-2. PMID 31414211. verified
  5. Swanson AA, Raghunathan A, Jenkins RB, et al. Spinal cord ependymomas with MYCN amplification show aggressive clinical behavior. J Neuropathol Exp Neurol 2019;78(9):791–797. doi:10.1093/jnen/nlz064. PMID 31373367. verified
  6. Raffeld M, Abdullaev Z, Pack SD, et al. High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma. Acta Neuropathol Commun 2020;8(1):101. doi:10.1186/s40478-020-00973-y. PMID 32641156. verified
  7. Bandopadhayay P, Silvera VM, Ciarlini PDSC, et al. Myxopapillary ependymomas in children: imaging, treatment and outcomes. J Neurooncol 2016;126(1):165–174. doi:10.1007/s11060-015-1955-2. PMID 26468139. verified
  8. Fassett DR, Pingree J, Kestle JR. The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients. Report of five cases and review of the literature. J Neurosurg 2005;102(1 Suppl):59–64. doi:10.3171/ped.2005.102.1.0059. PMID 16206735. verified
  9. Lucchesi KM, Grant R, Kahle KT, et al. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database. J Neurooncol 2016;130(1):133–140. doi:10.1007/s11060-016-2218-6. PMID 27423644. verified
  10. Abdallah A, Emel E, Gündüz HB, et al. Long-term surgical resection outcomes of pediatric myxopapillary ependymoma: experience of two centers and brief literature review. World Neurosurg 2020;136:e245–e261. doi:10.1016/j.wneu.2019.12.128. PMID 31899399. verified
  11. Abdulaziz M, Mallory GW, Bydon M, et al. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity. Neurosurg Focus 2015;39(2):E8. doi:10.3171/2015.5.FOCUS15164. PMID 26235025. verified
  12. Plotkin SR, O'Donnell CC, Curry WT, et al. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients. J Neurosurg Spine 2011;14(4):543–547. doi:10.3171/2010.11.SPINE10350. PMID 21294614. verified
  13. Farschtschi S, Merker VL, Wolf D, et al. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2. Acta Neurol Scand 2016;133(6):475–480. doi:10.1111/ane.12490. PMID 26369495. verified
  14. Kim DH, Kim JH, Choi SH, et al. Differentiation between intramedullary spinal ependymoma and astrocytoma: comparative MRI analysis. Clin Radiol 2014;69(1):29–35. doi:10.1016/j.crad.2013.07.017. PMID 24034546. verified
  15. Jagtiani P, Karabacak M, Bahadir Z, et al. Pediatric intramedullary spinal cord tumors: a national cancer database analysis of demographics, patterns of care, and survival. Clin Neurol Neurosurg 2024;244:108457. doi:10.1016/j.clineuro.2024.108457. PMID 39042966. verified
  16. Sala F, Palandri G, Basso E, et al. Motor evoked potential monitoring improves outcome after surgery for intramedullary spinal cord tumors: a historical control study. Neurosurgery 2006;58(6):1129–1143. doi:10.1227/01.NEU.0000215948.97195.58. PMID 16723892. verified
  17. Yao KC, McGirt MJ, Chaichana KL, et al. Risk factors for progressive spinal deformity following resection of intramedullary spinal cord tumors in children: an analysis of 161 consecutive cases. J Neurosurg 2007;107(6 Suppl):463–468. doi:10.3171/PED-07/12/463. PMID 18154014. verified
  18. McGirt MJ, Chaichana KL, Atiba A, et al. Incidence of spinal deformity after resection of intramedullary spinal cord tumors in children who underwent laminectomy compared with laminoplasty. J Neurosurg Pediatr 2008;1(1):57–62. doi:10.3171/PED-08/01/057. PMID 18352804. verified

Verification (2026-11-16):

Caveats: